hotspot -WSS

hotspot

author：comprehensive 2025-10-01 15:29:13 - browse：8

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Wegovy cuts risk of cardiovascular events by 20%, study finds

knowledge

WSS

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Germany receives 178 compensation applications from gay servicepeople over discrimination

Discs beat pads, tampons for heavy menstrual flow, new study shows

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

First medicine developed to treat MASH expected to be approved soon

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

New air purifier tech could be key to improving indoor air quality

A deep dive into Applied Therapeutics’ data, and questions on Cassava

BioMarin wins approval for gene therapy to treat hemophilia A

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

What does generative AI mean for health care? We asked experts

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Sports medicine is finally prioritizing gender equality

Wegovy cuts risk of cardiovascular events by 20%, study finds

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Former medical device CEO who sold dummy, plastic parts convicted of fraud

focus

Change Healthcare payments predicted restored March 15

Biden praises World Series champion Astros for impact off the field during White House celebration

Choosing scientific sides in the fight against Alzheimer's

Ohioans vote in high

First medicine developed to treat MASH expected to be approved soon

Biden praises World Series champion Astros for impact off the field during White House celebration

knowledge

focus

entertainment

hotspot